Table 1.
Normal cartilage | Chondrosarcoma | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient | COX-2 | EP1 | α2 integrin | β1 integrin | Patient | Grade | Location | COX-2 | EP1 | α2 integrin | β1 integrin |
1 | 100% | 100% | 100% | 100% | 13 | II | Pelvis | 402% | 378% | 501% | 399% |
2 | 81% | 127% | 95% | 99% | 14 | II | Scapular | 479% | 391% | 389% | 420% |
3 | 93% | 139% | 112% | 103% | 15 | II | Pelvis | 331% | 297% | 391% | 475% |
4 | 112% | 81% | 98% | 75% | 16 | II | Humerus | 339% | 289% | 402% | 512% |
5 | 71% | 66% | 74% | 86% | 17 | II | Humerus | 597% | 661% | 505% | 612% |
6 | 55% | 69% | 67% | 97% | 18 | II | Scapular | 697% | 788% | 667% | 669% |
7 | 61% | 55% | 85% | 92% | 19 | II | Pelvis | 711% | 791% | 719% | 739% |
8 | 39% | 41% | 75% | 66% | 20 | II | Pelvis | 456% | 505% | 522% | 712% |
9 | 102% | 112% | 101% | 108% | 21 | II | Scapular | 421% | 571% | 565% | 705% |
10 | 111% | 121% | 112% | 122% | 22 | II | Pelvis | 397% | 339% | 631% | 669% |
11 | 91% | 81% | 77% | 72% | 23 | II | Scapular | 338% | 397% | 668% | 612% |
12 | 121% | 108% | 102% | 105% | 24 | II | Pelvis | 897% | 721% | 612% | 579% |
25 | I | Pelvis | 322% | 259% | 339% | 312% | |||||
26 | I | Pelvis | 217% | 267% | 337% | 332% | |||||
27 | I | Humerus | 205% | 201% | 269% | 279% | |||||
28 | I | Scapular | 272% | 288% | 307% | 309% | |||||
29 | I | Scapular | 301% | 322% | 365% | 331% |
Results are expressed as % of patient 1